We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Abbott Diagnostics

  Silver Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
19 Jun 2021 - 22 Jun 2021
Virtual Venue

AI-Powered Imaging Software Aids Coronary Stenting

By HospiMedica International staff writers
Posted on 11 May 2021
Print article
Image: OCT and Ultreon Software image calcium deposits in blood vessels (Photo courtesy of Abbot)
Image: OCT and Ultreon Software image calcium deposits in blood vessels (Photo courtesy of Abbot)
A new imaging platform merges optical coherence tomography (OCT) with artificial intelligence (AI) for enhanced visualization of calcium-based blockages.

The Abbott Laboratories (Abbot Park, IL, USA) OCT technology uses near-infrared (NIR) light and the Dragonfly OpStar imaging catheter to provide high-definition (HD) images from within a blood vessel, improving physicians’ assessment of blockages in those vessels and optimizing decisions related to stent selection, placement, and deployment. The system is powered by Ultreon 1.0 Software to automatically detect degree and thickness of calcification, highlight calcification arc and maximal thickness, display calcification angle and thickness values throughout pullback in real-time, and highlight calcification overlays on the vessel with co-registration views.

In addition, it can automatically detect external elastic lamina (EEL) and lumen to help identify landing zones for accurate stent placement; provide vessel diameter measurements; facilitate measuring of lesion length and identification of optimal user-adjusted stent landing zones; aid stent length selection through co-registration; provide side-by-side viewing of live and co-registered angio to help physicians guide precise stent deployment; and ensure optimal stent expansion and apposition by instantaneous display of expansion and apposition results.

“Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures,” said Nick West, MD, chief medical officer and divisional vice president of global medical affairs at Abbott’s vascular business. “Ultreon Software can potentially improve physician and patient experience by utilizing a systematic process, reducing variability and increasing accuracy of diagnosis and application of therapies.”

“Ultreon’s customizable user interface and AI detection will make decision-making faster and reduce procedural variability, especially for the increasing number of physicians who are learning to utilize OCT imaging over other more traditional imaging technologies,” said Jose Mª de la Torre Hernández, MD, head of interventional cardiology at Hospital Universitario Marques de Valdecilla (Santander, Spain). “The automatic display of details with Ultreon reduces uncertainty during the preparation for stent placement and allows for increased accuracy to help us deliver better care to our patients.”



Print article
Radcal

Channels

Copyright © 2000-2021 Globetech Media. All rights reserved.